Quarterly Transactions Made in Esperion Therapeutics, Inc. (ESPR)
This table provides information about the institutional ownership of Esperion Therapeutics, Inc. (ESPR). The information is specifically focused on institutions that hold shares of Esperion Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 1,326,506 | 1,479,786 | 2,806,292 | 4,219,653 | 1,760,591 | 5,980,244 | -3,173,952 | |
| Q4 2021 | 12,166,977 | 19,410,914 | 31,577,891 | 664,406 | 1,811,451 | 2,475,857 | 29,102,034 | |
| Q1 2022 | 7,939,261 | 1,126,756 | 9,066,017 | 2,622,751 | 8,315,127 | 10,937,878 | -1,871,861 | |
| Q2 2022 | 4,787,344 | 4,754,042 | 9,541,386 | 5,691,772 | 380,554 | 6,072,326 | 3,469,060 | |
| Q3 2022 | 9,503,940 | 2,256,548 | 11,760,488 | 3,779,850 | 6,057 | 3,785,907 | 7,974,581 | |
| Q4 2022 | 12,100,594 | 11,070,780 | 23,171,374 | 6,128,790 | 0 | 6,128,790 | 17,042,584 | |
| Q1 2023 | 17,241,633 | 7,620,056 | 24,861,689 | 9,412,040 | 0 | 9,412,040 | 15,449,649 | |
| Q2 2023 | 11,473,005 | 3,845,693 | 15,318,698 | 14,112,960 | 27,940 | 14,140,900 | 1,177,798 | |
| Q3 2023 | 16,299,366 | 1,616,223 | 17,915,589 | 5,704,509 | 0 | 5,704,509 | 12,211,080 | |
| Q4 2023 | 5,585,877 | 6,707,922 | 12,293,799 | 16,058,061 | 0 | 16,058,061 | -3,764,262 | |
| Q1 2024 | 45,669,093 | 23,266,627 | 68,935,720 | 8,949,360 | 60 | 8,949,420 | 59,986,300 | |
| Q2 2024 | 38,328,273 | 13,077,671 | 51,405,944 | 22,231,488 | 0 | 22,231,488 | 29,174,456 | |
| Q3 2024 | 14,558,883 | 1,610,606 | 16,169,489 | 13,338,694 | 0 | 13,338,694 | 2,830,795 | |